相关实验视频
Updated: Jul 11, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
在初级预防环境中,他类药物和新发糖尿病:根据基线糖尿病风险分层的更新元分析
Walter Masson1, Martín Lobo2, Leandro Barbagelata3
1Cardiology Department, Hospital Italiano de Buenos Aires, Perón 4190. Ciudad Autónoma de Buenos Aires, C1199ABB, Buenos Aires, Argentina. walter.masson@hospitalitaliano.org.ar.
在初级预防中使用静止剂会增加新发糖尿病的风险,特别是在高风险人群中. 这一元分析证实,只有当基线糖尿病率升高时,这种关联才是显著的.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 类固醇药物治疗广泛用于心血管疾病的初级预防.
- 在使用他类药物时,观察到新发糖尿病的风险增加.
- 人口特征可能会影响他类药物与糖尿病的关联.
结论:
- 在初级预防中使用静止剂与新发糖尿病的风险增加有关.
- 与他类药物相关的新发糖尿病的风险在患糖尿病发病率较高的人群中显著增加.
- 在考虑在初级预防环境中使用他类药物治疗时,风险分层是至关重要的.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Dipeptidyl Peptidase 4 Inhibitors